Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory
about
Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychoticsAntipsychotic prescribing: do conflict of interest policies make a difference?Emergency department visits by adults for psychiatric medication adverse eventsOff-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates.A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.
P2860
Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Changes in antipsychotic use a ...... d Drug Administration advisory
@ast
Changes in antipsychotic use a ...... d Drug Administration advisory
@en
type
label
Changes in antipsychotic use a ...... d Drug Administration advisory
@ast
Changes in antipsychotic use a ...... d Drug Administration advisory
@en
prefLabel
Changes in antipsychotic use a ...... d Drug Administration advisory
@ast
Changes in antipsychotic use a ...... d Drug Administration advisory
@en
P2093
P2860
P50
P356
P1476
Changes in antipsychotic use a ...... d Drug Administration advisory
@en
P2093
Alisa B Busch
G Caleb Alexander
Haiden A Huskamp
P2860
P304
P356
10.1002/PDS.3272
P577
2012-05-03T00:00:00Z